Markets

Xencor (XNCR) Catches Eye: Stock Adds 6.9% in Session

Xencor, Inc.XNCR was a big mover last session, as its shares rose almost 7% on the day. The upside followed the release of fourth-quarter results by the company which topped Street estimates. This also led to far more shares changing hands than in a normal session. Yesterday's rally continues the recent uptrend for the company, as the stock is now up over 20% in the past one-month time frame.

Over the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Xencor currently has a Zacks Rank #3 (Hold).

A better-ranked med-drugs stock is Auris Medical Holding AG EARS with a Zacks Rank #1 (Strong Buy).

Is XNCR going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

XENCOR INC (XNCR): Free Stock Analysis Report

AURIS MEDICAL (EARS): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

XNCR EARS

Other Topics

Investing Stocks

Latest Markets Videos